Octopus-backed AI biotech CellVoyant raises £7.6m to make stem cell therapies cheaper
Amount Raised
$7.6 Million
Round Type
Funding Round
BristolBiotechnologyInvestors
Description
University of Bristol spinout CellVoyant, which uses AI imaging technology to help stem cell therapy developers more efficiently manufacture new treatments, has raised £7.6m in seed funding.
Who else raised in Biotechnology around the same time
Companies in the same sectors as CellVoyant that raised within 45 days of this round, from Fundz verified event records.
- Adipo Therapeutics raised $1.9M (Seed) on March 7, 2024.
- Biobot Surgical raised $18M (Series B) on March 7, 2024.
- Alumis raised $259M (Series C) on March 7, 2024.
- Wobble Genomics Ltd raised $11M (Series A) on March 7, 2024.
- Vescent Technologies raised $5M (Seed) on March 7, 2024.
- Alumis raised $259M (Series C) on March 7, 2024.
Who to call at CellVoyant, and when
A new round usually means CellVoyant is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day CellVoyant raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CellVoyant, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CellVoyant. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CellVoyant raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
CellVoyant raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.